RLMD Price / Book | RELMADA THERAPEUTICS, INC.

RELMADA THERAPEUTICS, INC. (RLMD) Price / Book

2026-09-03: Price/Book Ratio 2.26.
2026-06-30: Price/Book Ratio 3.57.
2026-03-31: Price/Book Ratio 3.34.
2025-12-31: Price/Book Ratio 4.09.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.26
2026-06-30	3.57
2026-03-31	3.34
2025-12-31	4.09
2025-09-30	7.05
2025-06-30	1.25
2025-03-31	0.4
2024-12-31	0.44
2024-09-30	2.05
2024-06-30	1.47
2024-03-31	1.95
2023-12-31	1.46
2023-09-30	0.9
2023-06-30	0.67
2023-03-31	0.54
2022-12-31	0.75
2022-09-30	6.37
2022-06-30	2.9
2022-03-31	3.77
2021-12-31	3
2021-09-30	6.31
2021-06-30	5.77
2021-03-31	6.47
2020-12-31	4.96
2020-09-30	4.98
2020-06-30	5.36
2020-03-31	4.5
2019-12-31	4.87
2019-09-30	17.04
2019-06-30	9.5
2019-03-31	462.85
2018-12-31	95.43
2017-12-31	52.19
2017-09-30	32.55
2017-06-30	28.14
2017-03-31	15.47
2016-12-31	11.23
2016-09-30	12.7
2016-06-30	15.59
2016-03-31	8.01
2015-12-31	10.2
2015-09-30	15.6
2015-06-30	49.67
2015-03-31	1,271.22
2014-12-31	724.68

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
GALECTIN THERAPEUTICS INC (GALT)	United States	$0.399B	-11.06
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63